Fosphenytoin Dosing
For status epilepticus in adults, administer fosphenytoin 15-20 mg PE/kg IV at 100-150 mg PE/min; for children, use the same loading dose but infuse at 2 mg PE/kg/min (or 150 mg PE/min, whichever is slower). 1
Loading Doses
Status Epilepticus (Emergency Setting)
Adults:
- Dose: 15-20 mg PE/kg IV
- Infusion rate: 100-150 mg PE/min (maximum 150 mg PE/min)
- IM administration should NOT be used in status epilepticus due to delayed therapeutic levels 1
Pediatric (birth to <17 years):
- Dose: 15-20 mg PE/kg IV
- Infusion rate: 2 mg PE/kg/min OR 150 mg PE/min, whichever is slower 1
- IM administration should ordinarily NOT be used in pediatric patients 1
The 2014 emergency medicine guideline confirms the 18 mg PE/kg loading dose with maximum infusion rate of 150 PE/min, noting fewer adverse events with fosphenytoin compared to phenytoin 2. The 2008 pediatric guideline specifies neonates receive 10 mg/kg while children receive 20 mg/kg, with infusion not exceeding 1 mg/kg/min 3.
Non-Emergent Loading
Adults:
- Dose: 10-20 mg PE/kg IV
- Infusion rate: Maximum 150 mg PE/min 1
Pediatric:
- Dose: 10-15 mg PE/kg IV
- Infusion rate: 1-2 mg PE/kg/min OR 150 mg PE/min, whichever is slower 1
Maintenance Doses
Adults
- Initial maintenance: 4-6 mg PE/kg/day in divided doses
- Infusion rate: Maximum 150 mg PE/min
- Start maintenance 12 hours after loading dose 1
Pediatric
- Initial maintenance dose: 2-4 mg PE/kg given 12 hours after loading dose
- Subsequent maintenance: 4-8 mg PE/kg/day in divided doses (every 12 hours)
- Infusion rate: 1-2 mg PE/kg/min OR 100 mg PE/min, whichever is slower 1
Recent pediatric research suggests maintenance dosing every 12 hours is superior to every 24 hours, with 5-7.5 mg/kg/dose every 12 hours maintaining therapeutic levels more effectively 4. Population pharmacokinetic modeling supports 6 mg/kg/dose every 8 hours for optimal therapeutic range maintenance 5.
Adjustments for Organ Impairment
Hepatic or Renal Disease
Critical adjustment: Reduce infusion rate by 25-50% in patients with hepatic disease, renal disease, hypoalbuminemia, or elderly patients 6. These patients experience:
- Decreased protein binding of fosphenytoin
- Earlier peak phenytoin concentrations
- Increased unbound (free) phenytoin levels
- Higher risk of systemic adverse effects 7, 6
The conversion of fosphenytoin to phenytoin remains efficient in hepatic/renal disease, but close clinical monitoring is essential 7. Monitor unbound (free) phenytoin concentrations rather than total concentrations in these populations 1.
Monitoring
Timing of Serum Levels
- Do NOT measure phenytoin levels until conversion is complete:
- 2 hours after IV infusion ends
- 4 hours after IM injection 1
- Measuring earlier will overestimate phenytoin concentrations due to cross-reactivity with fosphenytoin 1
Optimal monitoring strategy in pediatrics: Measure at 2 hours and 12 hours after loading dose to safely adjust dosing 4
Target Concentrations
- Total phenytoin: 10-20 mcg/mL
- Unbound (free) phenytoin: 1-2 mcg/mL 1
- Use EDTA tubes for blood collection before complete conversion to minimize ex vivo conversion 1
Critical Safety Considerations
Continuous Monitoring Required
Monitor ECG, blood pressure, and respiratory function throughout infusion and for 10-20 minutes after completion (when peak phenytoin concentrations occur) 1
Common Pitfalls
- Never use IM route for status epilepticus - therapeutic levels are delayed 1
- Avoid IM administration in pediatric patients in general 1
- Fosphenytoin alone may not terminate status epilepticus; concomitant IV benzodiazepine is usually necessary 1
- Oral phenytoin should be used whenever possible due to cardiac and local toxicity risks with IV administration 1
Adverse Effects
Fosphenytoin has fewer adverse events than IV phenytoin, particularly less hypotension, bradyarrhythmias, cardiac arrest, and extravasation injuries 2. However, transient paresthesias and pruritus can occur at rapid infusion rates 6.
Special Populations
Neonates: Have increased toxicity risk due to decreased protein binding; phenobarbital is preferred over phenytoin/fosphenytoin 3. If fosphenytoin is used, consider lower doses (10 mg/kg) 3.